about
Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: a case-control study.High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinomaA nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinomaInflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolizationImpact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score AnalysisDerived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study.Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.Long-term therapy with sorafenib is associated with pancreatic atrophy.Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients.Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study.Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study.Percutaneous microwave ablation of larger hepatocellular carcinoma.Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative studyA novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinomaRole of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in ChinaHepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombusLoco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumorsThe role of miR-10b in metastatic pancreatic ductal adenocarcinomaTransarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study
P50
Q33677461-8612D0EB-9BCE-4A37-942C-D7721BB30D79Q33961903-D9689460-2F88-4C7C-A3A9-2C863EE46D83Q34265995-68228DCD-E9B3-40CF-9F19-FE3AE9B7D46FQ35182896-F7E60CB0-8B43-4F59-837C-CFC25BDE62ACQ35594248-2033344C-BFA2-4188-B6CC-F60D6801763CQ36121202-1339D642-7B60-44BA-88D2-A532721C87ECQ36186701-132C4C7E-9674-4846-B93E-224134688004Q36414408-D9A69CF6-2CD0-4BD8-8C84-9E1B2646B386Q36562370-DE4B61F4-D380-4CD5-A1A3-4BC75E2C91FBQ36684702-23138345-544F-4E9D-9B57-4217370F856AQ36822692-8A26EF5E-FBB3-40CB-AFDF-6DAF764DC4CDQ36824936-1D73A9B3-2F91-47E6-8402-DC7BF1F2BF1AQ37367449-811C0CB9-D6E4-4BB2-91DA-2BEB29EB4966Q37373904-3EB4593B-DA24-41D7-92B5-FAEF2DAC0F36Q38170197-8DFA2947-EEBC-4328-BE30-F253F00AE609Q38935553-65E67B44-25A8-4861-90CF-65BB811A92EEQ40110698-D22092D4-983A-4DE0-9810-511994F5B9E4Q40792612-1E636FEE-7C55-484C-AFF3-5A80EC62FFA6Q41336102-0A0FA64E-6E54-43B4-9958-5625961F2353Q41721660-6AC4B992-1044-4903-96B9-5D625BBE91D5Q41721665-06CA6E9A-0E3E-4A4F-ABE8-1DF4298527C1Q42173132-129667C7-C746-493F-8F5D-BCD281E0EC32Q44401177-E35F525A-50CC-437B-B61B-B9C778CBE452Q45351611-628AD32A-F6AE-4925-9827-D5D97C08506DQ45384679-F176ABE2-5BA5-478A-ABB9-BCE9C9F57EA5Q47282943-71360E40-6E22-44B4-987C-DBF1BD6BA6EAQ50785082-FC7A057C-8F62-44B5-89CE-44E7170D8127Q52599794-40C68E02-93F5-4053-9E4A-F3B051AC52EDQ52929135-3E665C90-B96B-44FF-9F34-7CBFADDA8AF9Q53111952-2F03BBF1-0831-4265-A95E-6F324AE7FEBCQ53153527-423A3849-00B8-46E6-90EB-CDE46E7076ACQ53157382-DF3E8A29-8D6A-471C-8FD9-16039379A8ECQ56775191-3941A905-17E4-4882-82D3-511F9AABDA5CQ59127090-57289836-401B-4CE5-8C56-CBA82B1C2BA7Q83164922-D14FD88B-9A73-472D-AB6A-4814266ECC3FQ83498126-132FC68F-C8CC-4A39-AD26-F5C6642916CDQ83576576-02F7AA1D-3212-415E-8D0F-970A795CBDC5Q84073094-9817773B-F3BE-44C0-8EA6-C527CEC4C1DFQ84340454-EF074BC8-DFDE-4FDC-A0AD-B0BD25FC0D02Q85026135-6DF467E5-D6A3-4B43-8FE4-DE75BB6E2CF9
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9752-4729
@en
name
Yaojun Zhang
@ast
Yaojun Zhang
@en
Yaojun Zhang
@es
Yaojun Zhang
@nl
type
label
Yaojun Zhang
@ast
Yaojun Zhang
@en
Yaojun Zhang
@es
Yaojun Zhang
@nl
prefLabel
Yaojun Zhang
@ast
Yaojun Zhang
@en
Yaojun Zhang
@es
Yaojun Zhang
@nl
P214
P244
P106
P1153
56949079200
P214
P244
nb2016004186
P31
P496
0000-0002-9752-4729
P7859
lccn-nb2016004186